|
76
|
280
|
4cv9A |
Mps1 kinase with 3-aminopyridin-2-one inhibitors |
|
74
|
274
|
4dbnA |
Crystal structure of the kinase domain of human b-raf with a [1,3]thiazolo[5,4-b]pyridine derivative |
|
108
|
336
|
4dh3A |
Low temperature x-ray structure of camp dependent protein kinase a catalytic subunit with high mg2+, atp and ip20 |
|
98
|
308
|
4cd0A |
Structure of l1196m mutant human anaplastic lymphoma kinase in complex with 2-(5-(6-amino-5-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2- yl)phenyl)ethoxy)pyridin-3-yl)-4-methylthiazol-2-yl)propane-1,2-diol |
|
93
|
292
|
4btmA |
Ttbk1 in complex with inhibitor |
|
105
|
338
|
4c36A |
Pka-s6k1 chimera with compound 15e (cct147581) bound |
|
77
|
264
|
4c3pA |
Structure of dephosphorylated aurora a (122-403) bound to tpx2 and amppcp |
|
88
|
301
|
4cfvA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
69
|
291
|
4c0tA |
Candida albicans pkh kinase domain |
|
106
|
340
|
4c34A |
Pka-s6k1 chimera with staurosporine bound |
|
94
|
308
|
4cnhA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 3-((1r)-1-(5-fluoro-2-methoxyphenyl)ethoxy)-5-(1-methyl-1h- 1,2,3-triazol-5-yl)pyridin-2-amine |
|
80
|
299
|
4cfxA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
108
|
412
|
4bwkA |
Structure of neurospora crassa pan3 pseudokinase |
|
72
|
263
|
4byiA |
Aurora a kinase bound to a highly selective imidazopyridine inhibitor |
|
81
|
271
|
4c7tA |
Focal adhesion kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor |
|
93
|
290
|
4btkA |
Ttbk1 in complex with inhibitor |
|
77
|
262
|
4c3rA |
Structure of dephosphorylated aurora a (122-403) bound to amppcp |
|
101
|
544
|
4cffA |
Structure of full length human ampk in complex with a small molecule activator, a thienopyridone derivative (a-769662) |
|
86
|
300
|
4cfwA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
145
|
454
|
4btfA |
Structure of mlkl |
|
47
|
171
|
4bvuA |
Structure of shigella effector ospg in complex with host ubch5c- ubiquitin conjugate |
|
81
|
279
|
4c4eA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
77
|
279
|
4c4hA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
95
|
308
|
4cmtA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 3-((1r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy)- 5-(3-(methylsulfonyl)phenyl)pyridin-2-amine |
|
77
|
280
|
4c4gA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
87
|
297
|
4cfmA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
107
|
322
|
4c02A |
Crystal structure of human acvr1 (alk2) in complex with fkbp12.6 and dorsomorphin |
|
87
|
309
|
4c8bA |
Structure of the kinase domain of human ripk2 in complex with ponatinib |
|
95
|
292
|
4btjA |
Ttbk1 in complex with atp |
|
107
|
340
|
4c35A |
Pka-s6k1 chimera with compound 1 (nu1085) bound |
|
96
|
309
|
4cmoA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 2-((1r)-1-((3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl) oxy)ethyl)-4-fluoro-n-methylbenzamide |
|
89
|
269
|
4c2wA |
Crystal structure of aurora b in complex with amp-pnp |
|
98
|
308
|
4cliA |
Structure of the human anaplastic lymphoma kinase in complex with pf- 06463922 ((10r)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16, 17-tetrahydro-2h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). |
|
83
|
261
|
4c3fA |
Structure of lck in complex with a compound discovered by virtual fragment linking |
|
87
|
302
|
4cfuA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
82
|
298
|
4bzdA |
Structure of cdk2 in complex with a benzimidazopyrimidine |
|
71
|
263
|
4byjA |
Aurora a kinase bound to a highly selective imidazopyridine inhibitor |
|
89
|
287
|
4c61A |
Inhibitors of jak2 kinase domain |
|
93
|
308
|
4ccbA |
Structure of the human anaplastic lymphoma kinase in complex with 3-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy)-5-(5-methyl-1h- pyrazol-4-yl)pyridin-2-amine |
|
108
|
337
|
4c38A |
Pka-s6k1 chimera with compound 21e (cct239066) bound |
|
87
|
300
|
4cfnA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
82
|
273
|
4bzoA |
Crystal structure of pim1 in complex with a pyrrolo-pyrazinone inhibitor |
|
121
|
409
|
4bwpA |
Structure of drosophila melanogaster pan3 pseudokinase |
|
81
|
272
|
4brxA |
Focal adhesion kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor |
|
95
|
310
|
4c57A |
Structure of gak kinase in complex with a nanobody |
|
78
|
279
|
4c4iA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
74
|
279
|
4c4jA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
95
|
314
|
4ckiA |
Crystal structure of oncogenic ret tyrosine kinase m918t bound to adenosine |
|
89
|
271
|
4c2vA |
Aurora b kinase in complex with the specific inhibitor barasertib |
|
75
|
307
|
4c58A |
Structure of gak kinase in complex with nanobody (nbgak_4) |
